Quick Answer
Ceribell, Inc. reported R&D Expense of $19.14 million for fiscal year 2025.
Ceribell, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $19.14M | +41.2% |
| 2024 | $13.56M | +50.8% |
| 2023 | $8.99M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.98M | +46.8% | +2.7% |
| June 30, 2025 | $4.85M | +48.4% | +14.3% |
| March 31, 2025 | $4.25M | +42.3% | +25.1% |
| September 30, 2024 | $3.40M | +47.1% | +3.8% |
| June 30, 2024 | $3.27M | — | +9.6% |
| March 31, 2024 | $2.98M | — | +29.3% |
| September 30, 2023 | $2.31M | — | — |
- Ceribell, Inc. showed an increase of +41.2% in R&D Expense compared to the prior fiscal year.
- Over the 2023–2025 period, Ceribell, Inc.’s r&d expense has grown by 112.8% (from $8.99 million to $19.14 million).
- The most recent figure is from Ceribell, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: